Miasuma 
Key Takeaways Moderna (NASDAQ: MRNA) jumped more than 10% as investors reassessed the company’s mRNA vaccine and oncology pipeline. The rally was driven by two major catalysts: FDA advisers backing Moderna’s mRNA flu vaccine and strong five-year melanoma data from Moderna’s personalized cancer vaccine program with Merck. MRNA stock is now being valued less as … Read more
Key Takeaways Damora Therapeutics (NASDAQ: DMRA) rose as investors focused on the company’s DMR-001 program, a potential targeted therapy for mutant calreticulin-driven blood cancers. DMRA stock is not moving because of commercial revenue or earnings. The company remains a clinical-development biotech story. The main catalyst is DMR-001, an anti-mutCALR antibody designed for patients with mutant … Read more
Key Takeaways ClearOne (NASDAQ: CLRO) surged more than 100% after announcing a merger agreement with Cortigent, a wholly owned subsidiary of Vivani Medical. The move was not driven by a recovery in ClearOne’s legacy conferencing or AV business. Instead, CLRO stock jumped because investors are now pricing in a potential reverse merger into a brain-computer … Read more
Key Takeaways Figma (NYSE: FIG) jumped after strong Q1 2026 earnings, faster revenue growth, and a higher full-year revenue outlook. The company reported Q1 revenue of $333.4 million, up 46% year over year, showing growth acceleration from the prior two quarters. Figma also raised its 2026 revenue guidance and delivered strong free cash flow, reinforcing … Read more
Key Takeaways Polibeli Group (NASDAQ: PLBL) surged after announcing a non-binding MOU to evaluate a potential 100MW AI computing center project in Thailand. The announcement triggered strong interest because AI data centers, power capacity, and Southeast Asia AI infrastructure remain hot market themes. However, the MOU is still early-stage and non-binding. Polibeli has not yet … Read more
Key Takeaways Genuine Parts Company (NYSE: GPC) surged after reports that O’Reilly Automotive made a cash bid for GPC’s automotive parts business. The reported bid puts a spotlight on the potential value of GPC’s NAPA-led Global Automotive segment. GPC had already announced a plan to separate its automotive and industrial businesses into two independent public … Read more
Key Takeaways Editas Medicine (NASDAQ: EDIT) moved sharply higher as investors focused on the company’s EDIT-401 program, recent preclinical data, and renewed interest in CRISPR gene editing stocks. EDIT-401 is Editas Medicine’s lead in vivo gene editing candidate for hyperlipidemia and atherosclerotic cardiovascular disease risk reduction. The company reported strong non-human primate data showing roughly … Read more
Key Takeaways RIVN stock moved sharply higher after Rivian reported stronger-than-expected Q2 2026 deliveries and raised its full-year delivery outlook. Rivian produced 12,613 vehicles and delivered 12,194 vehicles in Q2 2026, beating the company’s prior delivery range of 9,000 to 11,000 vehicles. The company also raised its 2026 delivery guidance from 62,000–67,000 vehicles to 65,000–70,000 … Read more
Key Takeaways Sable Offshore (SOC) surged after the company priced a large common stock and convertible senior notes offering. The move was not driven by a clean earnings beat. It was more likely a high-volatility rebound after financing terms became clearer. The company is trying to refinance debt tied to Exxon Mobil while restarting production … Read more
Key Takeaways dLocal (DLO) surged as investors reacted to strong Q1 2026 growth in total payment volume, revenue, and gross profit. The company reported TPV growth of 73% year over year, revenue growth of 55%, and gross profit growth of 40%, reinforcing its position as a high-growth emerging market payments infrastructure company. The bullish case … Read more